Who is sponsoring autoSVREGDE?

autoSVREGDE is sponsored by Philips Respironics.

What condition does autoSVREGDE study?

autoSVREGDE studies Central Sleep Apnea, Mixed Sleep Apnea, Cheyne-Stokes Respiration, Complex Sleep Apnea.

What drugs are being tested in autoSVREGDE?

Interventions: DreamStation BiPAP autoSV.

What is the status of autoSVREGDE?

autoSVREGDE is currently COMPLETED.

Last reviewed 2023-10-02 · How we verify

A Prospective Multicenter Registry of Patients With Sleep Disordered Breathing Treated With DreamStation BiPAP autoSV. (autoSVREGDE)

NCT03421704 COMPLETED

This multi-center observational study will prospectively collect data from patients who have an indication for servo ventilation therapy. This registry is intended to characterize the patient populations that may benefit from DreamStation BiPAP autoSV therapy (PR DS-autoSV, Philips Respironics, Monroeville, PA) in real life settings. In addition, this registry will assess adherence to the PR DS-autoSV therapy, the therapeutic benefits, collect morbidity and mortality data of servo ventilation in patients with central sleep apnea (CSA) and complex sleep-disordered breathing (SDB).

Details

Lead sponsor	Philips Respironics
Status	COMPLETED
Enrolment	129
Start date	Thu Jan 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Apr 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Central Sleep Apnea
Mixed Sleep Apnea
Cheyne-Stokes Respiration
Complex Sleep Apnea

Interventions

DreamStation BiPAP autoSV

Countries

Germany